
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
CCC
Market Cap: zł10.7b
Engages in the retail sale of footwear and other products in Poland, Central and Eastern Europe, and Western Europe.
CCC
zł138.70
7D
-2.3%
1Y
-31.3%
Wirtualna Polska Holding
Market Cap: zł1.6b
Through its subsidiaries, engages in the media, advertising, and e-commerce businesses in Poland.
WPL
zł53.60
7D
-2.9%
1Y
-31.6%
ZE PAK
Market Cap: zł1.1b
Produces and sells electricity and heat in Poland.
ZEP
zł22.10
7D
0.5%
1Y
41.8%
Ryvu Therapeutics
Market Cap: zł453.4m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł24.70
7D
7.6%
1Y
-45.6%
Erbud
Market Cap: zł328.1m
Engages in the construction business in Poland and internationally.
ERB
zł27.50
7D
-3.0%
1Y
-16.2%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł260.4m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł47.10
7D
4.7%
1Y
-14.7%
Makarony Polskie
Market Cap: zł250.7m
Engages in the manufacture and sale of pastas for various consumers in Poland.
MAK
zł23.00
7D
1.8%
1Y
14.4%
Grupa Kapitalowa IMMOBILE
Market Cap: zł233.8m
Operates in industry, construction, automation and power engineering, hospitality, and development industries in Poland and internationally.
GKI
zł3.12
7D
2.6%
1Y
64.2%
Artifex Mundi
Market Cap: zł161.2m
Develops and publishes computer games worldwide.
ART
zł13.50
7D
1.7%
1Y
-18.7%
NOCTILUCA SPÓLKA AKCYJNA
Market Cap: zł148.6m
Develops, produces, and sells OLED emitter material chemical compounds.
NCL
zł95.40
7D
1.5%
1Y
14.9%
PCF Group Spólka Akcyjna
Market Cap: zł132.3m
Engages in the development and production of video games in Poland and internationally.
PCF
zł3.68
7D
-3.2%
1Y
-61.4%
Molecure
Market Cap: zł126.1m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.
MOC
zł6.12
7D
0%
1Y
-32.7%
Poltreg
Market Cap: zł118.0m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł25.30
7D
2.0%
1Y
-47.9%